Magdalena Polańska - Skrzypczyk

Magdalena Polańska-Skrzypczyk, MD

Doctor Magdalena Polańska-Skrzypczyk specialises in cardiology. She treats adults, including English-speaking patients.
She takes part in a wide range of conferences and workshops, constantly advancing her professional skills. She has co-authored many publications in the field of cardiology. She is a graduate of the Medical Academy of Warsaw and specialises in the treatment of cardiomyopathy.

 

The doctor deals with:

• Conservative cardiology
• Test reports: Holter ECG, Holter RR, exercise tests
• Treatment of cardiomyopathy

Education:

• Graduate of the 2nd Faculty of Medicine, Medical Academy of Warsaw
• Cardiology specialist
• Currently pursuing a PhD at the Cardinal Stefan Wyszyński National Institute of Cardiology

Professional experience:

• Specialisation internship: Central Clinical Hospital of the Ministry of Internal Affairs and Administration (postgraduate internship)
• Institute of Cardiology, Department of Cardiology and Interventional Angiology — cardiology residency
• Institute of Cardiology, Cardiomyopathy Department
• Outpatient clinic LUXMED
• Outpatient clinic POLMED
• Konstancin Health Resort, Cardiac Rehabilitation Department
• Medicover Hospital, Al. Rzeczypospolitej 5 in Warsaw

Trainings, courses and certificates:

• Incremental prognostic value of renal function on short term outcomes in patients with ST elevation myocardial infarction treated with primary angioplasty. The ANIN Myocardial Infarction Registry. Polańska M., Karcz M., Bekta P., Kępka C., Kruk M., Przyłuski J., Księżycka E., Ciszewski A., Witkowski A., Rużyłło W. ESC Congress, Stockholm 2010. Poster
• Prognostic value of renal dysfunction on angiographic and both short and midterm clinical outcomes after ST – segment elevation treated with primary angioplasty. The ANIN Myocardial Infarction Registry. Polańska M., Karcz M., Bekta P., Kępka C., Kruk M., Przyłuski J., Księżycka E., Ciszewski A., Witkowski A., Rużyłło W. 14th International Congress of the Polish Cardiac Society, Poznań 2010. Poster
• Major bleeding is a predictor of mid-term mortality in STEMI patients treated with primary PCI. The ANIN Myocardial Infarction Registry. Polańska-Skrzypczyk M., Karcz M., Bekta P., Kępka C., Rużyłło W., Ciszewski A., Witkowski A. ESC Congress, Paris 2011. Poster
• Long term effect on minimising pain-to-balloon time on mortality in ST-elevation infarction. The ANIN Mycoardial Infarction Registry. Magdalena Polańska-Skrzypczyk, Maciej Karcz, Paweł Bekta, Cezary Kępka, Jakub Przyłuski, Mariusz Kruk, Ewa Księżycka, Andrzej Ciszewski, Witold Rużyłło, Adam Witkowski. ESC Congress, Munich 2012. Oral presentation
• Decreased eGFR is associated with increased all-cause and cardiovascular mortality even nine years after ST-Elevated Myocardial Infarction (STEMI). The ANIN Myocardial Infarction Registry. Polańska-Skrzypczyk M., Karcz M., Bekta P., Kępka C., Przyłuski J., Kruk M., Księżycka E., Ciszewski A., Rużyłło W., Witkowski A. ESC Congress, Barcelona 2013. Poster
• A new risk scale for assessing long-term prognosis of STEMI patients treated with pPCI. Magdalena Polańska, Maciej Karcz, Paweł Bekta, Cezary Kępka, Jakub Przyłuski, Mariusz Kruk, Witold Rużyło, Adam Witkowski. 8th International Congress of the Polish Cardiac Society, Poznań 2014. Poster
• Scientific grants:
• Assessment of the prognostic value of serum NT-pro BNP levels in patients with hypertrophic cardiomyopathy
• Applicability of cardiac magnetic resonance imaging in stratifying the risk of sudden death in hypertrophic cardiomyopathy
• Antiarrhythmic therapy versus catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy

Publications:

• Co-author of “The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.”
• Co-author of “Total ischaemic time and 9-year outcomes in STEMI patients treated with pPCI.”
• Co-author of “Prognostic value of renal function in patients with ST-elevation myocardial infarction treated with primary angioplasty.” ANIN Myocardial Infarction Registry
• Co-author of “Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.”
• Co-author of “Relationship between cycle length of typical atrial flutter and double potential interval after achievement of complete isthmus block.”
• Co-author of “Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions”, 2018, 12(5)pp. 402-406.

 

Location:

Adress
Aleja Rzeczypospolitej 5,
02-972 Warsaw